Search Results - "Zhang, Maoquan"
-
1
Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model
Published in Frontiers in oncology (2024)“…Sentinel lymph node biopsy (SLNB) in breast cancer patients with positive clinical axillary lymph nodes (cN1+) remains a topic of controversy. The aim of this…”
Get full text
Journal Article -
2
Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis
Published in Experimental and therapeutic medicine (01-12-2018)“…Macrophages, whether M1 or M2 subtype, have been found to be implicated in the pathogenesis of osteoarthritis (OA). However, no study regarding the status of…”
Get full text
Journal Article -
3
Expression of Rab25 correlates with the invasion and metastasis of gastric cancer
Published in Chinese journal of cancer research (01-04-2013)“…The objective of this study was to determine the expression of the important vesicle trafficking- regulating factor Rab25 in human gastric cancer tissues, to…”
Get full text
Journal Article -
4
Effect of Wu-Wei-Gui-Shao decoction on complete Freund's adjuvant-induced arthritis rats
Published in Tropical journal of pharmaceutical research (01-09-2020)“…Purpose: To investigate the anti-rheumatic potential of Wu-Wei-Gui-Shao decoction (WGD) and its possible mechanism of action. Methods: Adjuvant arthritis (AA)…”
Get full text
Journal Article -
5
Nomogram for predicting preoperative axillary lymph node status in male breast carcinoma: a SEER population-based study
Published in Translational cancer research (28-04-2023)“…Sentinel lymph node biopsy (SLNB) has been recommended as a replacement for axillary lymph node dissection (ALND) in male breast carcinoma (MBC) with clinical…”
Get full text
Journal Article -
6
MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting β-TrCP2
Published in Acta biochimica et biophysica Sinica (01-12-2016)“…Pancreatic cancer is an aggressive malignancy. The median survival rate remains low, indicating that the identification of novel biomarkers and therapeutic…”
Get full text
Journal Article